ask="5.26"
ask_size="300"
average_daily_volume="75221"
bid="4.79"
bid_size="2000"
book_value="5.08"
change="+0.12"
change_from_200_day_moving_average="-0.40"
change_from_50_day_moving_average="0.57"
change_from_52_week_high="-7.53"
change_From_52_week_low="1.56"
change_in_percent="+2.35%"
close="5.22"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-20.26M"
eps_estimate_current_year="-8.61"
eps_estimate_next_quarter="-0.80"
eps_estimate_next_year="-2.57"
ex_dividend_date="N/A"
float_shares="6404000"
high="5.55"
high_52_weeks="12.75"
last_trade_date="2/17/2017"
last_trade_price="5.22"
last_trade_size="290"
last_trade_time="4:00pm"
low="5.08"
low_52_weeks="3.66"
market_capitalization="70.10M"
moving_average_200_day="5.62"
moving_average_50_day="4.65"
name="Aeglea BioTherapeutics
Inc."
notes="N/A"
one_year_target_price="17.00"
open="5.10"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-7.20%"
percent_change_from_50_day_moving_average="+12.28%"
percent_change_from_52_week_high="-59.06%"
percent_change_from_52_week_low="+42.62%"
previous_close="5.10"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.00"
price_per_sales="13.79"
revenue="4.97M"
shares_outstanding="13430000"
short_ratio="2.04"
stock_exchange="NGM"
symbol="AGLE"
volume="191080"
weeks_range_52="3.66 - 12.75"
